Clinical trial Recruiting at 1 site Interventional Ages 1 Month to 18

Nurse-led ultrasound to place IVs in children with hard-to-find veins

Official title: Difficult Venous Access in Pediatric Patients: Paramedical Care Using Ultrasound Guidance

Run by CHU de Reims · NCT06465121 · Data updated 2026-11-12

This trial will test whether trained nurses using ultrasound can help get IVs more quickly and successfully in hospitalized children with hard-to-find veins compared with the usual palpation/visual method.

More Catheter Related Complication trials

Quick facts

Study typeInterventional
Ages1 Month to 18 Years
SexAll
Enrollment120 (estimated)
SponsorCHU de Reims
Academic / other
Locations1 site (Reims)
StatusRecruiting
StartedFebruary 17, 2026
Main results expectedAugust 2027
Study endsSeptember 2027
Registry record updatedFebruary 20, 2026
Trial IDNCT06465121 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Hospitalized children aged 1 month to under 18 years at CHU de Reims who need peripheral IV access and have a DIVA score of 4 or higher, with parental consent, are ideal candidates.

Probably not a fit

Newborns under 1 month, premature neonates, patients with known vascular pathology, those on hemodialysis with an arteriovenous fistula, or children judged hemodynamically or respiratorily unstable are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Hospitalized pediatric patients who need a peripheral IV and meet a difficult intravenous access score threshold are randomized to have catheterization performed either by standard visualization and palpation or by ultrasound guidance from a trained nurse. State-certified nurse investigators trained in ultrasound perform the ultrasound-guided insertions when enrolled patients require IV access in participating pediatric departments at CHU de Reims. The trial compares insertion success rates and frequency of related adverse events between the two approaches. Consent from parents or legal guardians (and assent when appropriate) is required before randomization.

Why it matters

Potential benefit: If successful, this approach could increase first-attempt IV success, reduce delays and pain, and lower complication rates for children with difficult IV access.

How similar studies have gone: Previous studies have shown ultrasound guidance improves peripheral IV success in children and adults, and nurse-led ultrasound insertion has demonstrated promising results in other settings.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria :

* age ≥ 1 month and \< 18 years
* intravenous catheter insertion indicated for hospital care
* DIVA (Difficult Intravenous Access Scale) score ≥ 4
* hospitalized in one of the pediatric departments of the Reims University Hospital
* who agree to participate in the study (if old enough to understand) and for whom the consent of the holder(s) of parental authority has been obtained
* affiliated to a social security scheme

Exclusion Criteria:

* Newborns (\< 1 month) and premature babies hospitalized in neonatal intensive care, neonatology and maternity units
* Known vascular pathology
* Hemodialysis with arteriovenous fistula
* Unstable hemodynamic and/or respiratory clinical state according to the judgment of the medical team

Where it's running

  • Chu Reims
    Reims, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.